| Particulars |
| Company Name |
Bacil Pharma Ltd |
Year End |
202603 |
| Full Year |
| Equity (Rs Cr.) |
14.35 |
B.V. Rs |
17.60 |
| Sales Rs Cr. |
0.00 |
NP Rs Cr. |
1.56 |
| NP Var% |
1,291.00 |
Div% |
0.00 |
| CPS Rs |
1.10 |
EPS Rs |
1.10 |
| Traded Value(Rs Lakhs) |
44.28 |
52 Week High |
62.00 |
| 52 Week Low |
27.00 |
Price BSE |
49.00 |
| Price NSE |
0.00 |
Market Capital(Rs Cr.) |
70.89 |
| P/C Ratio |
45.20 |
P/E Ratio |
45.20 |
| Price Vs.BV |
2.78 |
|
| Latest Quarter |
| Year End |
202603 |
Sales Rs Cr. |
0.00 |
| NP Rs Cr. |
0.62 |
NP Var % |
3,885.00 |
| Trailing Twelve Months |
| Year End |
202603 |
Sales |
0.00 |
| OPM |
0.00 |
NP |
0.39 |
| NP Var% |
1290.65 |
EPS |
1.08 |
| PE |
45.73 |
|
|